Key result
Hypertension in postmenopausal women is an often underestimated cardiovascular risk factor that presents either as an isolated disease or as part of the metabolic syndrome.
Highlights the importance of recognizing and managing hypertension and metabolic syndrome in postmenopausal women due to their increased cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Hypertension warrants closer scrutiny in postmenopausal women; leaves open optimal screening and management strategies pending prospective validation.
Cardiovascular risk is poorly perceived by women, especially during the peri- and postmenopausal period when susceptibility to cardiovascular events increases. Nevertheless in Europe, 55% of women versus 43% of men currently die of cardiovascular disease. Blood pressure is one of the most powerful and accurate determinants of cardiovascular status and risk. Despite its importance, hypertension is often underestimated and undiagnosed, especially in women. Various mechanisms are implicated to play a role in the blood pressure increase in women at the time of menopause. Hypertension can be considered an isolated disease, more typical of elderly women, or part of the metabolic syndrome, more frequent in early postmenopausal women. The metabolic syndrome, a clustering of lipid and nonlipid cardiovascular risk factors, is estimated to affect approximately 20-30% of the middle-aged population and its prevalence appears to be increasing in the worldwide population.
No takes yet. Share an insight, caveat, or question.
Nuzzo et al. (2010) conducted a review in Hypertension and metabolic syndrome. Hypertension in postmenopausal women is an often underestimated cardiovascular risk factor that presents either as an isolated disease or as part of the metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: